首页> 外文OA文献 >First-day step-down to oral outpatient treatment versus continued standard treatment in children with cancer and low-risk fever in neutropenia. A randomized controlled trial within the multicenter SPOG 2003 FN study
【2h】

First-day step-down to oral outpatient treatment versus continued standard treatment in children with cancer and low-risk fever in neutropenia. A randomized controlled trial within the multicenter SPOG 2003 FN study

机译:在患有中性粒细胞减少症的癌症和低危发烧儿童中,第一天下调为口服门诊治疗,而继续采用标准治疗。多中心SPOG 2003 FN研究中的随机对照试验

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BACKGROUND: The standard treatment of fever in chemotherapy-induced neutropenia (FN) includes emergency hospitalization and empirical intravenous antimicrobial therapy. This study determined if first-day step-down to oral outpatient treatment is not inferior to continued standard regarding safety and efficacy in children with low-risk FN.\udPROCEDURE: In a randomized controlled non-blinded multicenter study, pediatric patients with FN after non-myeloablative chemotherapy were reassessed after 8-22 hours of inpatient intravenous antimicrobial therapy. Low-risk patients were randomized to first-day step-down to experimental (outpatient, oral amoxicillin plus ciprofloxacin) versus continued standard treatment. Exact non-inferiority tests were used for safety (no serious medical complication; non-inferiority margin of difference, 3.5%) and efficacy (resolution of infection without recurrence, no modification of antimicrobial therapy, no adverse event; 10%).\udRESULTS: In 93 (26%) of 355 potentially eligible FN episodes low-risk criteria were fulfilled, and 62 were randomized, 28 to experimental (1 lost to follow-up) and 34 to standard treatment. In intention-to-treat analyses, non-inferiority was not proven for safety [27 of 27 (100%) vs. 33 of 34 (97%; 1 death) episodes; 95% upper confidence border, 6.7%; P = 0.11], but non-inferiority was proven for efficacy [23 of 27 (85%) vs. 26 of 34 (76%) episodes; 95% upper confidence border, 9.4%; P = 0.045]. Per-protocol analyses confirmed these results.\udCONCLUSIONS: In children with low-risk FN, the efficacy of first-day step-down to oral antimicrobial therapy with amoxicillin and ciprofloxacin in an outpatient setting was non-inferior to continued hospitalization and intravenous antimicrobial therapy. The safety of this procedure, however, was not assessable with sufficient power.
机译:背景:化学疗法诱发的中性粒细胞减少症(FN)发烧的标准治疗方法包括紧急住院和经验性静脉抗菌药物治疗。这项研究确定了低风险FN儿童在接受门诊治疗的第一天降级是否不逊于持续的标准。\ ud步骤:在一项随机对照的非盲多中心研究中,FN后的儿科患者住院静脉抗菌治疗8-22小时后,重新评估了非清髓性化疗。低危患者被随机分为实验组(门诊,口服阿莫西林加环丙沙星)与继续标准治疗相比较的第一天。确切的非劣效性测试用于安全性(无严重的医学并发症;非劣效性差异,3.5%)和功效(感染的消退率,无复发,未改变抗微生物治疗,无不良事件; 10%)。\ udResults :在355例潜在合格的FN发作中,有93例(26%)满足了低风险标准,随机分配了62例,实验进行28例(随访失败1例),标准治疗34例。在意向性治疗分析中,安全性并未证明非劣效性[27/27(100%)vs. 33/34(97%; 1死亡)。可信度上限为95%,6.7%; P = 0.11],但非劣效性被证实[27例中有23例(85%)比34例中有26例(76%);可信度上限为95%,为9.4%; P = 0.045]。方案分析证实了这些结果。\ ud结论:对于低风险FN患儿,门诊患者使用阿莫西林和环丙沙星进行口服抗菌治疗的首日下调疗效不亚于继续住院和静脉内抗菌治疗治疗。但是,如果有足够的能力,则无法评估此过程的安全性。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号